Why Cherries Are Good for Us

Cherries are typically classified as either sweet or tart. The sweet varieties include Bing, Lambert, and Rainier cherries, which in the U.S. are grown mainly in Washington, Oregon, and Idaho. In contrast, tart cherries include the Montmorency and Balaton varieties, which are grown primarily in Michigan.
Cherries, as well cherry juice, have long been used by traditional healers as a folk remedy for gout. Today, we know that both sweet and tart cherries contain phenolics, naturally occurring compounds in plants that possess anti-inflammatory and antioxidant properties. Studies have suggested cherries may help to lower serum uric acid levels in the body--high levels of which cause gout.

A Long-Time Remedy for Pain

The main phenolics found in cherries are called anthocyanins, which are the pigments responsible for the colorful skins of some fruits and leaves. In general, the darker a cherry's color, the higher its anthocyanin content. Interestingly, it's now been shown that anthocyanins block two enzymes, COX-1 and COX-2, which are involved in the formation of a class of undesirable inflammatory compounds called prostaglandins. In this way, anthocyanins function similarly to drugs like aspirin and the non-steroidal, anti-inflammatory drugs (NSAIDs) that we use to control pain.
This is why for centuries healers have advocated eating tart cherries for conditions involving inflammation and pain, including:

• arthritis
• gout
• muscle pain
• back pain

This is also why today tart cherries are thought to be useful in diabetes and neurodegenerative diseases.

Tart Cherries as a Sleeping Aid?

Compared to most other foods, two tart varieties of cherries, Balaton and Montmorency, contain relatively high levels of the antioxidant melatonin, a hormone that helps regulate our sleep, with the Montmorency cherries containing about six times more melatonin than the Balatons.
A recent study from the UK, published online ahead of print in the European Journal of Nutrition, looked at melatonin levels in the urine of 20 volunteers who consumed (or not) cherry juice. The participants were divided into two groups, one group drinking 30 cubic centimeters (1 ounce or 2 tablespoons) of tart cherry juice, and the other group a placebo, each day for seven days. After the week was over, the researchers found that the people in the tart-cherry group had significantly higher levels of melatonin in their urine, and had slept an average of 25 minutes longer per night than the placebo group. The tart-cherry group also slept five percent to six percent more "efficiently." (Sleep efficiency is a global measure of one's quality of sleep.)

Are tart cherries better for you than sweet cherries?

Studies involving tart cherries have involved only very small groups of participants, so we'll have to wait to see whether larger studies show that tart cherries are healthier than regular cherries, and in what quantities. Generally, tart cherries have been found to have higher concentrations of phenolics and anthocyanins than do sweet cherries. And tart cherries might be a bit more friendly to the waistline, since they're slightly lower in sugar. Half a cup of sweet cherries contains 9.3 grams of sugar and 46 calories, compared to 6.6 grams of sugar and 39 calories in an equal amount of tart cherries.

Where to Find Tart Cherries

Tart cherry juice, as well as fresh, frozen, canned (unsweetened), or dried tart cherries can be found in grocery stores, health-food stores, and online.

Possible Contraindications for Tart Cherries

Cherries contain sorbitol, a sugar alcohol found in some sugar-free gums, candies, and such. Please be aware that sorbitol can sometimes exacerbate symptoms in those people with irritable bowel syndrome (IBS), small intestine bacterial overgrowth (SIBO), and fructose malabsorption.
As always, I urge you to check with your doctor before adding anything to your usual regimen, even non-prescription and dietary changes--such as tart cherries.

Early Alzheimer’s detection - cost effective and easy

By Dr Ananya Mandal, MD

Boston researchers have reported a new method for detecting subtle brain changes in people who have no memory problems but who may already be in the earliest stages of Alzheimer’s disease.
The findings, published online today in the medical journal Neurology, may help speed clinical trials for potential Alzheimer’s treatments, according to Dr. Bradford Dickerson, an associate professor of neurology at Harvard Medical School and lead author of the study. “We need efficient, cost-effective ways to screen people for research,” said Dickerson, who also is a brain specialist at Massachusetts General Hospital. “This will potentially give us a tool that will help identify people in a more efficient manner.”
Dickerson explained that his method is not ready for use in physicians’ offices. Researchers and the medical community still must pinpoint reliable markers for the disease that could be used much the same way doctors now measure early signs of heart disease by monitoring patients’ cholesterol levels.
For screening the team used brain scans to measure the thickness in nine specific areas of the brain in 159 people who did not show signs of dementia or other cognitive problems. The brain regions were chosen based on prior studies that showed they shrink in patients with Alzheimer’s. The median age of the participants was about 76 years. Of the 159 people, 19 were classified as high risk, meaning that they likely were undergoing the earliest stages of Alzheimer’s disease because of the smaller size of their brain regions that corresponded to areas typically affected by the illness. Another 116 were deemed to be at average risk for the disease, and the remaining 24 at low risk.
At the beginning of the study and over the next three years, participants were also given tests that measured their memory and problem-solving abilities. The cerebral cortex is the outer layer of the cerebrum, the most highly developed part of the brain. It consists of grey matter - the cell bodies of neurons where processing of muscle control, sensory perceptions, memory, emotions and speech take place.
The researchers also looked at cerebrospinal fluid (CSF) samples from 84 participants after three years to check levels of amyloid protein, a hallmark of Alzheimer's.
They found that 60% of people with a thinner cortex had abnormal CSF amyloid levels similar to those seen in the brains of Alzheimer's patients. This compared with 36% of those with average cortical thickness and 19% of those with an unusually thick cortex.
There is no known cure for Alzheimer’s disease. But a growing number of researchers believe that the lack of progress may be because the drugs are now tested only in people whose Alzheimer’s is too advanced. Researchers are searching for ways to detect the disease at its earliest stages, before it damages critical brain cells, because they believe that’s when potential treatments would be most effective.
Many believe that an accumulation of a specific protein, known as beta amyloid, in the brains of Alzheimer’s patients may be a reliable marker to identify the disease early on. Dickerson’s study found that 60 percent of the group of participants identified at high risk for Alzheimer’s because of their smaller brain regions also had abnormal levels of amyloid in the fluid of their brains and spinal cord. In comparison, the abnormal amyloid levels were detected in 36 percent of those deemed to be at average risk, and 19 percent at low risk.
Susan Resnick, chief of the behavioral neuroscience laboratory at the National Institutes of Health, said Dickerson’s new method could give researchers a more accurate tool for pinpointing from the people with amyloid plaques those who would most likely go on to suffer an Alzheimer’s decline. This would be the group most likely to benefit from potential treatments, and would be the type of participants researchers need to find, Resnick said. “This is a disease that we believe starts 10 to 15 years before we see clinical symptoms,” Resnick said, “so we need these kinds of tools to try to understand the disease at the earliest possible stage.”
Dickerson said he hopes his method could be used to lower the costs for screening participants in upcoming clinical trials of potential Alzheimer’s treatments, such as one Brigham and Women’s Hospital researcher Dr. Reisa Sperling plans to start next year. Sperling hopes to begin a three-year study of an amyloid-clearing medication on as many as 1,000 people, 70 years old and older, whose brains show an accumulation of amyloid plaques but who don’t appear to be impaired. She said that the cost of the research is expected to be in the range of $100 million but that she hoped to lower that amount by finding more efficient ways to screen participants.
Dr Simon Ridley, from the charity Alzheimer's Research UK, said, “The ability to predict who will develop Alzheimer's disease is a key target for dementia research, as it would allow new treatments to be trialed early, when they are more likely to be effective. These findings add weight to existing evidence that Alzheimer's begins long before symptoms appear, although it's important to note that the study did not assess who went on to develop the disease. This research provides a potential new avenue to follow, but we need to see larger and longer-term studies before we can know whether this type of brain scan could accurately predict Alzheimer's.”

Maggots Quickly Clean Up Wounds, Study Shows

TUESDAY, Dec. 20 (HealthDay News) -- The surgeons' scalpel may have new (and wriggling) competition in cleaning troublesome wounds: maggots.

To the uninitiated the treatment may seem strange. But new French research suggests that bagging up live, sterile fly larvae in tightly meshed dressing packs and applying them to open sores can be a quick, safe and effective way to clear away dead tissue.

Actually, "maggot debridement therapy" (MDT) has a long history in medicine. And the new investigation suggests that this approach -- traditionally reserved for more severe wounds -- can be a quick, first-line therapy for less severe lesions.

"Twenty years ago, maggot therapy was performed mostly as a 'last resort' prior to amputation," for the treatment of non-healing wounds, explained Dr. Ronald A. Sherman, a "biotherapeutics" researcher at the University of California, Irvine, and the Los Angeles and Orange County health departments. He was not involved in the new study.

Sherman noted that past studies found that when used as a last resort (after antibiotics and surgery failed), maggot therapy eliminated the need for amputations in an estimated 40 to 60 percent of cases.

The treatment has gained ever-broader acceptance in recent years, with studies touting its safety record and effectiveness in less severe, non-emergency situations.

"(This) is one of those studies, and clearly supports those who include maggot therapy as part of their wound-care tool bag," Sherman said, by suggesting "that there is no reason to delay maggot therapy until the wound and underlying diseases have progressed."

The study, published online Dec. 19 in the Archives of Dermatology, was led by Dr. Kristina Opletalova, from the department of dermatology at the University of Caen Basse-Normandie at the Centre Hospitalier Universitaire de Caen in Caen, France.

To gauge the potential of maggot therapy, between 2005 and 2008 the researchers focused on 105 patients treated at two hospitals in France.

All the patients had open wounds on their lower limbs that were about 16 inches square or smaller in area, and less than three-quarters of an inch deep. The wounds had not yet healed, and were characterized by a mass of dead tissue ("slough") that had separated from living tissue.

About half the patients were randomly selected to receive MDT while the other half received conventional dressing treatment.

The team used Lucilia sericata maggots (larvae of the common green bottle fly), with each double-layered, spongy mesh cube filled with 80 sterile, live, maggots. The maggots were unable to move outside the confines of the dressing's seal. However, the bag's fiber housing allowed for air and fluid permeability, and the maggots were mobile inside the bags, allowing maggot excretions and secretions to reach the target wound.

Over a two-week period, patients had the maggot-filled bags applied to each wound four times. The control group received conventional treatment: wound scraping by means of a scalpel to remove dead tissue, followed by standard dressing of the exposed live tissue.

At the one-week treatment mark, the researchers found that MDT patients had significantly less dead tissue in their wounds than conventional treatment patients (roughly 55 percent versus 67 percent).

The benefits seemed to equalize by the two-week mark, however, with slough measurements between the two groups nearly the same.

The authors concluded that MDT can promote much faster removal of dead tissue during the first week of care for standard wounds. They said that this could be especially valuable when time is of the essence, as can be the case for patients awaiting skin grafts.

But the team also noted that though safe and painless, the benefits of maggot therapy do not exceed those of standard care over the longer term, nor does it shorten the overall time it takes to close up a wound. They therefore advised that physicians only turn to MDT during the first week of treatment.

Sherman, also director of the BioTherapeutics, Education & Research Foundation in Irvine, Calif., called the study "well-conceived" and "well-executed."

It "demonstrated that maggot therapy is safe and at least equally effective to conventional surgical wound care," he noted. "This is not a new finding, but their study is very important because it adds to our limited database on maggot therapy."

But Sherman also noted that more aspects of maggot therapy remain to be explored, such as the potential for so-called "free-range maggot therapy" in which bag-less larvae are placed in direct contact with the wound.

"While this is a powerful testament to the potency of the maggots' therapeutic secretions, we are still left wondering whether or not free-range maggots might have done any better," he said. But this, he noted, awaits further study.

The U.S. Food and Drug Administration approved maggot therapy in 2004 as a "device" used by prescription.

More information

Learn more about maggot treatment at the Wound Care Information Network.

Dynatronics Solaris 709 5-Channel Combination Ultrasound Unit

http://www.1medicalsupply.com/Dynatronics-Solaris-709-5-Channel-Combination-Unit-w-One-Soundhead-p-2911.html

Product Details

Ultrasound Patented multi-frequency Ultrasound 1, 2, 3 MHz Duty cycles: 10%, 20%, 50%, continuous Three soundheads available: 2 cm2, 5 cm2, 10 cm2 Ultrasound settings: up to 2 watts/cm2 Display both in watts and watts/cm2 Head warming Coupling Combo plus™ Stim input for electrotherapy Electrotherapy Number of channels 5 Number of dedicated High Volt channels 1 Interferential Premodulated Russian Biphasic High Volt Microcurrent Direct Current (probe only) Target and Target Sweep feature for Interferential Modifiable frequency ranges Single, reciprocal, co-contraction modes in Russian, Biphasic Selectable and customizable on/off times for High Volt, Biphasic and Russian Modify pulse rate, pulse width in Biphasic, Russian Microcurrent and High Volt therapy delivered with either electrodes or probes Select Microcurrent and High Volt polarity (positive, negative, or bipolar) Microcurrent conductance indicator Electrode conductance meter Direct Current delivered through MultiStim probe Light Therapy Infrared cluster probe (optional) Light Pad (with Booster Box) (optional) Laser point probe (optional) General Warranty (2 years) Battery-pack (optional) Protocol Reference Manual for Electrotherapy & Ultrasound Light Therapy Applications Manual (included with probe order) Carrying case (hard and soft) (optional) Cart (optional) http://www.1medicalsupply.com/Dynatronics-Solaris-709-5-Channel-Combination-Unit-w-One-Soundhead-p-2911.html

BeasyTrans Systems, Inc.

http://www.1medicalsupply.com/BeasyGlyder-PN-1300-32-inches-p-3205.html

The BeasyTrans Original, BeasyII and BeasyGlyder - Easy Transfer Systems provide an upright, dignified lateral slide, rather than any type of lift transfer. No lifting means that soreness and injury to the patient's shoulders and arms are greatly reduced and frequently eliminated. In addition, the Beasy technology is "tissue friendly." The friction caused by movement is absorbed by the system, not the user's skin.

" No Lift Transferring" is important to caregivers as well as the patient. Statistics show that nursing personnel, for example, are among the leaders in the labor force for lower back injury compensation claims. Numerous studies have linked these injuries directly to patient moving tasks. With a Beasy, "No Lift" transfer, the risk of injuries caused by lifting is greatly reduced.

All three models of the BeasyTrans System are made of ultra strong polymers which are patented products of the Dupont company. These materials reinforced resins are among the toughest plastics know to man.

Our boards have been used to transfer patients weighing over 400 lbs. and have been stress tested to over 1100 lbs. in laboratories without breakage. This board has a track guard covering the underside of the track. Its purpose is to keep "egg crate" and other soft cushioning systems from pushing into the track and obstructing the movement of the seat. The track guard is also removable for cleaning.

http://www.1medicalsupply.com/BeasyGlyder-PN-1300-32-inches-p-3205.html

Invacare HomeFill Oxygen Compressor IOH200 $2499.00

http://www.1medicalsupply.com/Invacare-HomeFill-Oxygen-Compressor-p-3229.html

 
The Invacare HomeFill(TM) complete home oxygen system defines ambulatory oxygen by allowing patients to fill their own high-pressure cylinders from a concentrator.

The HomeFill is a multi-stage pump that simply and safely compresses oxygen from any Invacare HomeFill compatible 5-liter or 10-liter concentrator into oxygen cylinders in sizes M2, ML4, ML6, M6, M9(C) and D.

The ability to fill their own cylinders gives ambulatory patients greater independence and freedom. Home care oxygen providers will also benefit from the virtual elimination of time-consuming and costly service calls associated with cylinder and-or liquid oxygen deliveries.

Connection and controls are designed for easy operation.

Patient can fill cylinders while receiving oxygen from the concentrator.

Gives ambulatory patients greater freedom and independence.

Virtually eliminates the high service costs of frequent deliveries of cylinders and-or liquid oxygen.

Small and lightweight.

http://www.1medicalsupply.com/Invacare-HomeFill-Oxygen-Compressor-IOH200-p-3229.html

Pain Relief Miracle Testimonial

A bump appeared out of nowhere on the side of my face between my eyebrow and hairline. It grew to about 3/4 of an inch in diameter and about 1/4 of an inch high. I applied PRM twice a day for about a month and it is now gone.......all that is left is a small freckle where it used to be. I saved hundreds of dollars and time and got an ideal result, all from this organic, holistic cure. PRM will be a permanent fixture in my medicine cabinet and recommend it to anyone!!


Thank you PRM!!

Sincerely,

Sophi Paul
Phoenix, AZ

Click below to find out for yourself:
http://www.1medicalsupply.com/Pain-Relief-Miracle-p-3224.html

Pain Relief Miracle

Jason Laird created Pain Relief Miracle in 2007 to help his mother with her debilitating Arthritis.
She couldn’t hold on to a simple water glass or button her own blouse. One day while in the car, with the windows up, she applied the topical gel to her hands and it instantly made Jason’s eyes burn and made him sneeze. The medicine smell was so overwhelming that he knew he had to do something.
She was using a very popular, commercially available, topical pain relief formula that she applied 10 times per day with NO relief.
Jason researched the ingredients in that product and found there were at least 2 that were manufactured by a chemical company. There was only ONE ingredient that actually had any decent properties, and that was Menthol, a topical analgesic!

Jason couldn’t find anything on the market that worked, didn’t have a menthol medicine scent, and at the same time was chemical free and free of harsh medicines with other side effects. So he used his Master’s Degree in Acupuncture and Chinese herbology, to create something for his mom that was safe, but most importantly, EFFECTIVE.
“I was sick of looking at products that said “for the TEMPORARY relief of this or that. This was my MOTHER! I wanted her to be FIXED.” Jason
“I created a formula that would help stop the pain AND heal her tendons, bones and muscle as well as treat the ROOT CAUSE of her pain. When she tried it, she said the pain and burning in her hands went away almost immediately. When people in my Acupuncture clinic heard about the formula, they asked to try it and had amazing results as well.
Up until June of 2010, it was only available to my patients at Rising Lotus Wellness Center in Casper, Wyoming. Then one day I received an email from a gentleman in Texas that heard about it. I thought to myself, “Hmm, maybe this can help more people!” Now we have Pain Relief Miracle and it is available to everyone. We are now selling int Nationally”
Jason developed this formula to just treat pain in his mother’s hands. However, with so many patients having used PRM, they have reported it treating things such as headache, shingles, dandruff , skin rashes, bug bites, fungus such as athlete’s foot and ringworm, plantar faciitis, knee and hip pain, acne. It even brought back a gentleman’s voice that he’d lost for the last year. He applied it externally to his throat. It has also strangely enough, treated hemorrhoids.
“I didn’t ask what led them to try it there” says Jason. “People have even said it effectively treats their pets for some of the same problems. I’m not sure about the hemorrhoids however.”
We hope that Pain Relief Miracle eliminates that which causes you suffering. Try it! Use it 3 times per day, and you will have results, We GUARANTEE it or we will give you your money back.
Our mission is to transform and positively impact the lives of every person that uses PRM by taking away their pain and suffering so you can live a better quality of life!


http://www.1medicalsupply.com/Pain-Relief-Miracle-p-3224.html

1medicalsupply.com

1MedicalSupply.com Introduces Medical Supplies for Retail and Home Level Users

Wednesday, November 23, 2011 – Available 7 days a week, to an endless list of constantly growing perennial customers, the ‘1 Medical Supply’ website is one of the biggest online medical dealers in the country. At the moment, the website is not only maintaining top Google placement, but it’s also recognized for its high level of credibility, long term durable products and a wide variety of medical supplies for customers from all walks of life.

Head over to www.1medicalsupply.com to sift through a variety of different medical goods, clinic supplies, bathroom accessories and much more.

According to the ‘1 Medical Supply’ management team, this online store transcends the levels of any typical fly-by-night E-commerce web platform through a stainless reputation. The website’s repute can be looked up with the help of a vast variety of well received feedback and onsite customer testimonials.

At the moment, ‘1 Medical Supply’ is in the midst of touting out clinic supplies, medical accessories, bed and bath packages and literally any product that has to do with making an average person’s life a little better and hassle free than it already is.

In order to provide a stable, and an equally enjoyable, shopping experience to potential customers, the website has worked hard to earn the distribution rights of all the featured products.

More so, unlike fellow competitor online stores, ‘1 Medical Supply’ takes pride in its diligent team of customer representatives. According to the company sources, the customer representatives are people who’re “extremely familiar with the products that are being inquired about at any time of the day” – so much so that every call ends up with a 100% satisfaction rate and long term business opportunities for the company.

For more information about medical supplies, upcoming news and general body health accessories, head over to the official ‘1 Medical Supply’ website at www.1medicalsupply.com today.

Contact:

1 Medical Supply

Website: www.1medicalsupply.com

Email: Kathy@1medicalsupply.com          

Phone No.:  1-877-771-6337